{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:18:59Z","timestamp":1789017539241,"version":"build-2803163510"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"\n Importance<\/jats:title>\n Paracetamol (acetaminophen) is the first-line analgesic and antipyretic recommended globally during pregnancy. Observational studies have reported associations with increased risks of autism spectrum disorder (ASD) and attention-deficit\/hyperactivity disorder (ADHD) in offspring, raising public and clinical concern; however, these findings may be substantially confounded by unmeasured familial factors.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To assess the association between prenatal paracetamol exposure and risk of ASD and ADHD in offspring using a sibling-matched study design to control for familial confounding.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based cohort study, conducted from January 1, 2001, to December 31, 2023, in Hong Kong, used deidentified electronic health records within a triangulation framework. From an initial cohort of 708\u202f020 mother-child pairs (approximately 43.3% with prenatally paracetamol exposure), sibling-matched cohorts were constructed of children from families with discordant prenatal paracetamol exposure and sufficient follow-up (\u22652 years for ASD and \u22655 years for ADHD). Data analysis was conducted from October 2, 2025, to March 24, 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Prenatal paracetamol exposure, identified from electronic dispensing records (British National Formulary [BNF], section 4.7.1) with data on drug name, strength, dosage, and prescription dates.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Incident diagnoses per the\n International Classification of Diseases, Ninth Revision, Clinical Modification,<\/jats:italic>\n for ASD (code 299) or for ADHD (code 314) or a prescription for ADHD-specific medication licensed in Hong Kong (methylphenidate, atomoxetine, or lisdexamfetamine [BNF, section 4.4]).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The final cohorts comprised 124\u202f333 children for ASD analysis (mean [SD] age, 9.3 [4.7] years; 61\u202f775 females [49.7%] and 62 558 males [50.3%]) and 97 285 for ADHD analysis (mean [SD] age, 7.6 [4.2] years; 48\u202f455 females [49.8%], 48\u202f830 [50.2%]). In the sibling-matched analyses, prenatal paracetamol exposure was not associated with the risk of ASD (adjusted hazard ratio [aHR], 1.00; 95% CI, 0.91-1.11) or ADHD (aHR, 1.01; 95% CI, 0.93-1.08). Null associations were consistent across exposure timing, cumulative dose, and usage patterns (sporadic, intermittent, persistent), and were robust in sensitivity analyses. However, positive associations were observed in conventional cohort analyses, and importantly, also in negative control analyses of prepregnancy exposure for ASD (HR, 1.12; 95% CI, 1.08-1.17) and ADHD (HR, 1.24; 95% CI, 1.20-1.28).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this population-based cohort study, a sibling-matched analysis found no evidence of an association between prenatal paracetamol exposure and the risk of ASD or ADHD in offspring. The positive signals observed in conventional studies are likely attributable to residual familial confounding. These findings provide important reassurance regarding the safety of indicated paracetamol use during pregnancy.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.2215","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:33:52Z","timestamp":1782747232000},"page":"1102","source":"Crossref","is-referenced-by-count":6,"title":["Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and\/or Attention-Deficit\/Hyperactivity Disorder Among Sibling-Matched Cohorts"],"prefix":"10.1001","volume":"186","author":[{"given":"Shan","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaowa","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Family Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China"},{"name":"The Bau Institute of Medical and Health Sciences Education, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Chi Wai","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Family Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ip","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Paediatrics and Adolescent Medicine, Hong Kong Children\u2019s Hospital, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Wai Yin","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China"},{"name":"University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tanuseputro","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China"},{"name":"Aston Centre of Excellence in Pharmacotherapy Optimisation and Pharmacoepidemiology Research, Aston Pharmacy School, Aston University, Birmingham, UK"},{"name":"School of Pharmacy, Macau University of Science and Technology, Macau SAR, China"},{"name":"Advanced Data Analytics for Medical Science Limited, Hong Kong SAR, China"},{"name":"Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China"},{"name":"Advanced Data Analytics for Medical Science Limited, Hong Kong SAR, China"},{"name":"Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China"},{"name":"Comprehensive Primary Healthcare Collaboratory, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"ioi260035r1","doi-asserted-by":"publisher","first-page":"B14","DOI":"10.1016\/j.ajog.2017.01.021","article-title":"Prenatal acetaminophen use and outcomes in children.","volume":"216","author":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"ioi260035r2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41574-021-00553-7","article-title":"Paracetamol use during pregnancy: a call for precautionary action.","volume":"17","author":"Bauer","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"ioi260035r3","doi-asserted-by":"publisher","first-page":"r2025","DOI":"10.1136\/bmj.r2025","article-title":"Trump\u2019s claims on Tylenol (paracetamol), vaccines, and autism-what\u2019s the truth?","volume":"390","author":"Lang","year":"2025","journal-title":"BMJ"},{"key":"ioi260035r6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-088141","article-title":"Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit\/hyperactivity disorder in offspring: umbrella review of systematic reviews.","volume":"391","author":"Sheikh","year":"2025","journal-title":"BMJ"},{"issue":"6","key":"ioi260035r7","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/ije\/dyw115","article-title":"Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms.","volume":"45","author":"Avella-Garcia","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"9","key":"ioi260035r8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/aur.1591","article-title":"Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: a Danish national birth cohort study.","volume":"9","author":"Liew","year":"2016","journal-title":"Autism Res"},{"issue":"7","key":"ioi260035r9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/brainsci8070127","article-title":"Maternal biomarkers of acetaminophen use and offspring attention deficit hyperactivity disorder.","volume":"8","author":"Ji","year":"2018","journal-title":"Brain Sci"},{"issue":"2","key":"ioi260035r10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamapsychiatry.2019.3259","article-title":"Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit\/hyperactivity disorder and autism spectrum disorder in childhood.","volume":"77","author":"Ji","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"ioi260035r11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamapsychiatry.2019.0774","article-title":"Association of maternal neurodevelopmental risk alleles with early-life exposures.","volume":"76","author":"Leppert","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"14","key":"ioi260035r12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2024.3172","article-title":"Acetaminophen use during pregnancy and children\u2019s risk of autism, ADHD, and intellectual disability.","volume":"331","author":"Ahlqvist","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"ioi260035r14","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/S3050-5038(25)00211-0","article-title":"Prenatal paracetamol exposure and child neurodevelopment: a systematic review and meta-analysis.","volume":"2","author":"D\u2019Antonio","year":"2026","journal-title":"Lancet Obstet Gynaecol Womens Health"},{"issue":"4","key":"ioi260035r15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41380-018-0070-0","article-title":"Genetics of attention deficit hyperactivity disorder.","volume":"24","author":"Faraone","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"10","key":"ioi260035r16","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamapsychiatry.2019.1411","article-title":"Association of genetic and environmental factors with autism in a 5-country cohort.","volume":"76","author":"Bai","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"ioi260035r17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ppe.70071","article-title":"Maternal acetaminophen use and offspring\u2019s neurodevelopmental outcome: a nationwide birth cohort study.","volume":"40","author":"Okubo","year":"2026","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"ioi260035r18","doi-asserted-by":"publisher","DOI":"10.1002\/jcv2.12020","article-title":"Acetaminophen use during pregnancy and offspring attention deficit hyperactivity disorder: a longitudinal sibling control study.","volume":"1","author":"Gustavson","year":"2021","journal-title":"JCPP Adv"},{"issue":"6","key":"ioi260035r19","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/ije\/dyt183","article-title":"Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study.","volume":"42","author":"Brandlistuen","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"3","key":"ioi260035r20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/aur.1536","article-title":"Genome-wide association study of autism spectrum disorder in the East Asian populations.","volume":"9","author":"Liu","year":"2016","journal-title":"Autism Res"},{"issue":"3","key":"ioi260035r21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","article-title":"Identification of common genetic risk variants for autism spectrum disorder.","volume":"51","author":"Grove","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"ioi260035r22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/humupd\/dmaa042","article-title":"Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety.","volume":"27","author":"Zafeiri","year":"2021","journal-title":"Hum Reprod Update"},{"issue":"3","key":"ioi260035r24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study.","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"ioi260035r25","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41591-024-02917-8","article-title":"Maternal diabetes and risk of attention-deficit\/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs.","volume":"30","author":"Chan","year":"2024","journal-title":"Nat Med"},{"key":"ioi260035r26","doi-asserted-by":"publisher","first-page":"j2350","DOI":"10.1136\/bmj.j2350","article-title":"Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study.","volume":"357","author":"Man","year":"2017","journal-title":"BMJ"},{"issue":"10","key":"ioi260035r27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","article-title":"Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age.","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"2","key":"ioi260035r28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/wps.20948","article-title":"Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children.","volume":"21","author":"Wang","year":"2022","journal-title":"World Psychiatry"},{"issue":"2","key":"ioi260035r29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000529141","article-title":"Maternal benzodiazepines and Z-drugs use during pregnancy and adverse birth and neurodevelopmental outcomes in offspring: a population-based cohort study.","volume":"92","author":"Chan","year":"2023","journal-title":"Psychother Psychosom"},{"issue":"6","key":"ioi260035r30","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/ije\/dyw314","article-title":"Triangulation in aetiological epidemiology.","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"7","key":"ioi260035r31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/jama.2025.22234","article-title":"Sibling comparisons to account for confounding in observational studies.","volume":"335","author":"Ahlqvist","year":"2026","journal-title":"JAMA"},{"issue":"3","key":"ioi260035r32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies.","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"1","key":"ioi260035r33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s43586-023-00259-2","article-title":"Using negative controls to adjust for unmeasured confounding bias in time series studies.","volume":"3","author":"Nature Reviews Methods Primers","year":"2023","journal-title":"Nat Rev Methods Primers"},{"issue":"Suppl 3","key":"ioi260035r34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1289\/ehp.00108s3511","article-title":"Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.","volume":"108","author":"Rice","year":"2000","journal-title":"Environ Health Perspect"},{"issue":"10","key":"ioi260035r35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","article-title":"Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.","volume":"5","author":"Raman","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"ioi260035r36","first-page":"217","article-title":"Sex and age differences in attention-deficit\/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11.","volume":"49","author":"Ramtekkar","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"ioi260035r37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41398-020-0699-8","article-title":"Genetic evidence of gender difference in autism spectrum disorder supports the female-protective effect.","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"6","key":"ioi260035r38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41574-022-00656-9","article-title":"Paracetamol use in pregnancy: neglecting context promotes misinterpretation.","volume":"18","author":"O\u2019Sullivan","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"ioi260035r39","doi-asserted-by":"publisher","first-page":"h2102","DOI":"10.1136\/bmj.h2102","article-title":"Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.","volume":"350","author":"Desai","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"ioi260035r40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"28","key":"ioi260035r41","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"6","key":"ioi260035r42","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/EDE.0000000000000541","article-title":"Carryover effects in sibling comparison designs.","volume":"27","author":"Sj\u00f6lander","year":"2016","journal-title":"Epidemiology"},{"key":"ioi260035r43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076365","article-title":"Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations.","volume":"385","author":"Brown","year":"2024","journal-title":"BMJ"},{"issue":"31","key":"ioi260035r44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215632120","article-title":"The contributions of rare inherited and polygenic risk to ASD in multiplex families.","volume":"120","author":"Cirnigliaro","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ioi260035r45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.","volume":"55","author":"Demontis","year":"2023","journal-title":"Nat Genet"},{"issue":"15","key":"ioi260035r46","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion.","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"CMAJ"},{"issue":"7411","key":"ioi260035r47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.","volume":"327","author":"Li","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"ioi260035r48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jamapediatrics.2024.4409","article-title":"Gestational exposure to nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in childhood.","volume":"179","author":"Tain","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"1","key":"ioi260035r49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13229-021-00464-4","article-title":"Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis.","volume":"12","author":"Antoun","year":"2021","journal-title":"Mol Autism"},{"issue":"5","key":"ioi260035r50","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/EDE.0b013e31825fa230","article-title":"Sibling comparison designs: bias from non-shared confounders and measurement error.","volume":"23","author":"Frisell","year":"2012","journal-title":"Epidemiology"},{"key":"ioi260035r4","unstructured":"Medicines and Healthcare products Regulatory Agency. MHRA confirms taking paracetamol during pregnancy remains safe and there is no evidence it causes autism in children. UK Government. Published September 22, 2025. Accessed April 8, 2026. https:\/\/www.gov.uk\/government\/news\/mhra-confirms-taking-paracetamol-during-pregnancy-remains-safe-and-there-is-no-evidence-it-causes-autism-in-children"},{"key":"ioi260035r5","unstructured":"World Health Organization. WHO statement on autism-related issues. Published September 24, 2025. Accessed April 8, 2026. https:\/\/www.who.int\/news\/item\/24-09-2025-who-statement-on-autism-related-issues"},{"key":"ioi260035r13","unstructured":"London School of Hygiene & Tropical Medicine. Expert Comment: Paracetamol use during pregnancy does not increase risk of autism. Published September 23, 2025. Accessed April 8, 2026. https:\/\/www.lshtm.ac.uk\/newsevents\/news\/2025\/expert-comment-paracetamol-use-during-pregnancy-does-not-increase-risk-autism"},{"key":"ioi260035r23","unstructured":"Hong Kong Hospital Authority. Clusters, Hospitals & Institutions. Accessed April 8, 2026. https:\/\/www.ha.org.hk\/"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2850975\/jamainternal_luo_2026_oi_260035_1788184625.4213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:01:15Z","timestamp":1788879675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2850975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.2215","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}